This study was undertaken to further examine the role of the host response to parvovirus B19 in the development of symptoms and consequences of viral persistence. Genomic DNA from 42 patients with symptomatic B19 infection was analyzed using the HuSNP assay (Affymetrix), and the results were compared with those from analysis of 53 healthy control individuals. Fifty-seven single-nucleotide polymorphisms were identified that were significantly associated with symptomatic infection. Total RNA from peripheral blood mononuclear cells from 57 B19-seropositive and 13 B19-seronegative donors was analyzed by hybridization to a singlecolor microarray representing 9522 human genes. Ninety-two genes were shown to be differentially expressed. Differential expression was confirmed in 6 of 38 genes (SKIP, MACF1, SPAG7, FLOT1, c6orf48, and RASSF5) tested using real-time quantitative polymerase chain reaction in a different group of healthy subjects. Genes identified in both studies play a functional role in the cytoskeleton, integrin signaling, and oncosuppression, themes that have been shown to be important in parvovirus infections.
*04, and *07 alleles [4] . This finding suggests a genetic predisposition to development of symptoms during acute infection; however, the possible role of singlenucleotide polymorphisms (SNPs) within genes whose roles are not directly linked with the immune response remains undetermined.
In addition to the genomic influences described above, it is unknown whether there are long-term effects on host gene regulation that are due to the persistence of the viral genome [5] . The parvovirus B19 genome may persist after acute infection and may remain detectable in various tissues, including skin, testis, bone marrow, and synovium [6] .
In the present study, we address 2 important questions regarding the pathogenesis of B19 infection, which hitherto remained unanswered. First, are there genetic predispositions to symptomatic B19 infection that are not directly linked with the immune response? We have addressed this by determining the frequency of each of 1494 human SNPs in symptomatic infected persons and comparing these values with those in healthy persons from the same continent. By this approach, we identified 57 SNPs within genes that are accepted not to influence the immune response and that are associated with acute symptomatic B19 infection.
Second, what are the long-term consequences for the human host of B19 infection? We have addressed this by examining gene expression in peripheral blood mononuclear cells (PBMCs) from seropositive versus seronegative healthy persons and identifying differentially expressed genes. By this approach, using microarrays and real-time polymerase chain reaction (PCR), we identified 6 genes that are reproducibly differentially expressed.
SUBJECTS, MATERIALS, AND METHODS

SNPs Associated with Acute Symptomatic B19 Infection
Patients with symptomatic B19 infection. Patients gave written consent in accordance with the guidance of the ethics committees of Central Manchester and Royal Brompton, Harefield, and the National Heart and Lung Institute (NHLI), London. The human-experimentation guidelines of the US Department of Health and Human Services and those of the authors' institutions were followed. Forty-two patients with acute B19 infection were identified by detection of serum anti-B19 IgM in response to suggestive symptoms, as part of routine clinical practice. Clinical information for all but 4 patients have been published elsewhere [7, 8] (table 1) . All patients were white and from northwestern England, except for 1 Italian woman (patient 8) and 1 Jewish woman (patient 17). Ten milliliters of peripheral blood was drawn from each patient into EDTA tubes, and genomic DNA was extracted using a phenol-chloroform method. Anti-parvovirus B19 IgM and IgG were detected in serum by use of an ELISA (Biotrin), in accordance with the instructions of the manufacturer. B19 DNA was detected by nested PCR as described elsewhere [2] .
Affymetrix HuSNP assay. Simultaneous typing of genomic DNA for 1494 human SNPs was performed using the Affymetrix HuSNP chip. This approach has been successfully applied to the study of loss of heterozygosity in cancer [9] and allelic differences in gene expression [10] . Of the genes represented on the chip, only 27 were directly linked with the immune response (ITGB2, NFKBIA, CD59, IL-16, TGFBRIII, ALCAM,  LGALS8, CD46, TNFRSF19, IFIT2, CD79A, IL-19, NFKBI, G1P2,  IFI16, CXCL14, CD34, HLA-DOA, ITGB5, IFI27, BCAP29, CSF3,  IFI30, HLA-DPA1, IFNAR2 , HLA-DRA, and ICSBP1). Detailed information on the HuSNP chip is available elsewhere [10] . The steps of multiplex PCR amplification, chip hybridization, chip staining, and chip scanning were all conducted in accordance with the GeneChip HuSNP mapping assay manual (P/ N 700308; Affymetrix [http://www.affymetrix.com/]). For each SNP, the frequency of occurrence of A and B alleles was calculated for all subjects as a group. Allele frequencies for the B19-infected subjects were compared with those for 53 population control individuals from western Europe, provided by Affymetrix. Although the B19 infection status of the control group was unknown, it was assumed to reflect the B19 infection status of the population of western Europe. The strength of association between allele frequencies in the B19-infected group versus those in the population control group was estimated, using con-2 ϫ 2 tingency tables, by either x 2 or Fisher's exact analysis. Where appropriate, Yates's (x 2 ) corrections were applied. Confirmation of HuSNP results by use of Taqman real-time PCR. Taqman real-time PCR was used to confirm genotyping identified by the HuSNP assay for the SNPs rs1132 (CNN3), rs3835 (XRCC5), rs17103 (APBB4), rs17125 (MYLK), and rs1585 (CRADD), by use of the ABI PRISM 7700 system in accordance with the instructions of the manufacturer (Applied Biosystems).
Differential Gene Expression in B19-Seropositive Healthy Subjects
Enrollment of blood donors and processing of total RNA samples. Subjects gave written consent in accordance with the guidance of the ethics committees of East Dorset and Royal Brompton, Harefield, and the NHLI. The human-experimentation guidelines of the US Department of Health and Human Services and those of the authors' institutions were followed. Healthy blood donors were enrolled from the East Dorset division of the National Blood Service (NBS). The NBS restricts donors in accordance with strict criteria (see http://www.blood .co.uk/). Additional exclusion criteria were ingestion of antibiotics, steroids, or antidepressants during the preceding 3 months. Seventy healthy blood donors were enrolled for microarray analysis. The B19-seropositive and -seronegative sections of this group were age and sex matched.
Twenty milliliters of blood was drawn as part of routine blood donation and immediately placed in cell preparation tubes containing density-gradient solution and EDTA (BD Biosciences). PBMCs were isolated by density-gradient centrifugation. Total RNA was extracted using Trizol (Invitrogen), washed in PBS, and assessed by spectrometry (Nanodrop). Total RNA samples had absorbance ratios (A260/280) of 1.9-1.95. Approximately 10 mg of total RNA was shipped to Nimblegen (Madison, WI) at room temperature in 100% ethanol for array testing. Sample preparation was performed as described elsewhere [11] .
Microarray design and analysis. A custom microarray was manufactured by Nimblegen by use of maskless array synthesis (http://www.nimblegen.com/). The human genes in this design ( ) were selected from the Homo sapiens entries in the n p 9522 RefSeq collection of sequences as of August 2002 (http://www .ncbi.nlm.nih.gov/RefSeq/). Ten probes were selected from the 3 1 kb of each target gene. Probes were spaced evenly over the length of the target region (i.e., р1 kb). Each probe was 24 nt in length. For each perfect-match (PM) probe, there was also a mismatch (MM) probe that differed by 1 nt. Hybridization of the sample to the array, washing, and scanning were performed as described elsewhere [11] . The average difference values for each gene were calculated by taking the mean of the intensities for the PM probes specific to each target minus the mean of the intensity of the MM probes. Further analysis was performed using BRB ArrayTools (version 3.02; Molecular Statistics and Bioinformatics Section, National Cancer Institute), developed by R. Simon and A. Peng (http://linus.nci.nih.gov/ BRB-ArrayTools.html), and GeneSpring (version 5.1; Silicon Genetics). Average difference values were normalized, and a class comparison protocol was used to identify genes whose expression levels differed significantly at a level of у1.5-fold between the 2 groups. Values for differentially expressed genes were used to cluster all 70 subjects, by use of GeneSpring.
Confirmation of gene array results by Taqman real-time PCR.
Taqman real-time PCR (Applied Biosystems) was used to confirm the significance of genes identified by array experiments in a different group of 38 healthy subjects, 21 of whom were se- Table 3 . A subset of genes identified by microarrays that were also tested by real-time polymerase chain reaction (PCR) and that showed fold differences between seropositive and seronegative groups. Genes for which quantitative PCR showed significant differences between groups in the same direction as in microarray experiments.
c Genes for which quantitative PCR showed significant differences between groups. ropositive and 17 of whom were seronegative; these groups were age and sex matched. cDNA was prepared from total RNA from PBMCs by use of the random hexamer method of reverse transcription, in accordance with the instructions of the manufacturer (Applied Biosystems). Reactions were performed in triplicate in a 1-mL reaction volume in Taqman Universal PCR Mastermix, by use of the ABI PRISM 7900HT instrument (Applied Biosystems). cDNA samples were tested for 38 target gene assays (see table 3 ) along with the following endogenous controls: HMBS, HPRT-1, GAPDH, and eukaryotic 18S rRNA. Fluorogenic probes were 5 labeled with 6-carboxyfluorescein and 3 labeled with minor groove binder nonfluorescent quencher. For fluorescent signal detection, ROX was used as the internal passive reference dye. GAPDH gave the least-variable results in all samples and was used as the endogenous reference control. The threshold cycle (Ct) for each gene/sample pair was compared with a calibrator sample, and a DCt value was used to calculate a relative quantity of gene expression (RQ) compared with the calibrator. Finally, RQ values were normalized to GAPDH expression. The F test for equality of SDs was used to compare mean RQ values for each gene in test versus control groups.
Taqman real-time PCR for the B19 VP2 and NS1 genes. Taqman assays were designed for the B19 NS1 and VP2 genes, on the basis of conserved sequences. These were used to test a panel of 49 cDNA samples that had been prepared from PBMC total RNA in a group of 49 healthy blood donors, 29 of whom were seropositive and 20 of whom were seronegative. Tenfold dilutions ( ) of DNA extracted from a 10 Ϫ3 dilution of n p 10 viremic serum containing the Stu strain of B19 virus (provided by B. Cohen, Health Protection Agency, London) were used as standards [12] . All reactions were performed in triplicate.
RESULTS
SNPs Associated with Acute Symptomatic B19 Infection
Patients with symptomatic acute parvovirus B19 infection. Forty-two patients with acute B19 infection (serum anti-B19 IgM positive) were studied. These patients had an age range of 2 months to 52 years, with a mean age of 32.8 years and a female-male ratio of 5:1. Symptoms consisted of rash, arthritis, fatigue, thrombocytopenia, lymphadenopathy, myalgia, intrauterine fetal death preceded by a rash, and meningoencephalitis. In certain cases, there was concurrent anemia. Serum B19 DNA was detected in 40 patients (table 1) .
Human SNP genotyping. In the HuSNP assay, the overall percentage pass (i.e., the proportion of SNP assays that produced a valid result) ranged from 51% to 85%, with a mean of ∼72%. Therefore, overall, the number of SNP calls that were successful ranged from 714 to 1190, with a mean of 1008, out of a total of 1494. Comparison of allele frequencies of B19-infected patients with those in control subjects revealed 57 SNPs that had a significantly different frequency of occurrence between the test and control groups ( ); for 24 SNPs, the P р .05 association was highly significant ( ) (table 2) . Of these P р .001 57 SNPs, there was available gene information for 38 (table 2) . Among the SNPs showing a significant association with acute symptomatic B19 infection ( ), many could be catego-P р .05 rized according to function: cytoskeleton ( ); cell cycle n p 11 ( ); cell growth, including division and cancer ( ); n p 5 n p 5 apoptosis ( ); DNA binding, replication, and repair (n p n p 3 5); a receptor important for growth of bone marrow cells (n p 1); receptor-mediated endocytosis ( ); and the ubiquin p 1 tin-proteasome pathway ( ) (table 2) . Available positional n p 1 information for these SNPs indicated that they could be categorized according to the following: untranslated mRNA (n p 20), intron ( ), coding mRNA/synonymous ( ), n p 11 n p 2 known gene/unknown position ( ), and intergenic/unn p 5 known (
). There was no association between the fren p 19 quency of carriage of particular SNPs and the development of particular clinical manifestations of B19 infection.
Taqman real-time PCR genotyping confirmed data provided by the HuSNP assay for 5 of 5 human SNPs tested (rs1132 
Differential Gene Expression in B19-Seropositive Healthy Subjects
Human gene expression. Among the 70 subjects included in the microarray analysis, the mean age was 46.5 years, and the female-male ratio was 1.6:1. Fifty-seven subjects were seropositive, and 13 were seronegative. The mean age and femalemale ratio for seropositive and seronegative groups were equivalent. Statistical analysis of microarray data revealed that 92 genes showed differential expression between classes (у1.5-fold difference) that was statistically significant ( ) (table 3) . P ! .001 Hierarchical clustering using profiles of the 92 genes revealed that the seronegative subjects clustered in 2 groups, one with 4 subjects and the other with 9 subjects (figure 1).
Information on gene ontogeny obtained from the Source database revealed molecular ( ), cellular ( ), and n p 32 n p 16 biological ( ) functions, with involvement in RNA polyn p 7 merase II (TFII-I, DR1, BTF3, SIAHBP1, LRRFIP1, and TFIIS), RNA polymerase III (GTF3C2, ZNF143, and IVNS1BP), ubiquitin-mediated proteolysis (PSMD13, RNF26, FBXL5, and G1P2), actin cytoskeleton (SKIP, MACF, ARPC4, TPM1, C2orf6, and PPP4C), rapid division (MRPS6, MRPL20, SART2, and RASSF5), lymphocyte activation (LTB, RASSF5, and CD97), cell cycle (RBBP4, CHAF1A, S100A9, STRN3, and BIRC1), negative regulation of cell proliferation (RBBP4, PPP2R1A, and FNTA), tumor suppression (RBBP4, FRAG1, and RASSF5), apoptosis (LTB, PPP4C, BTF3, and BIRC1), and DNA binding and repair (SETDB1, ADPRTL2, H2AFY, H2AFX, CHAF1A, and RPA2). Real-time PCR was used to compare the expression of 38 of these genes in total RNA samples from a different panel of healthy subjects ( ; 17 seronegative and 21 seropositive) n p 38 and confirmed statistically significant differential expression for 15 genes; 6 (16%) of these showed the same relationship between groups as in array experiments ( figure 2 and table 3 ). In general, the differences in expression identified by PCR were smaller than those identified in microarrays (table 3) . Functional roles for these 6 genes included roles in the cytoskeleton (SKIP, MACF1, SPAG7, and FLOT1), integrin signaling (FLOT1 and RASSF5), HLA class III (c6orf48), and tumor suppression (RASSF5) (table 4). Viral gene expression. Real-time PCR for B19 NS1 and VP2 genes in cDNA samples revealed negative results in all subjects tested ( ), whereas an expected graded response was obn p 38 served for the 10-fold dilutions of extracted viremic serum (data not shown).
DISCUSSION
In the present study, we set out to identify genes and metabolic pathways that are important in the pathogenesis of parvovirus B19 infection at 2 distinct time points: at the time of acute symptomatic infection and at a time point after complete resolution. The rationale for the gene expression project is that B19 virus may persist at a low level for long periods in tissues long after viremia has ceased in seropositive persons [13] , and this phenomenon may play a role in the recognized state of immune activation that may persist for several years after acute infection [2] and may also be important in development of B19-associated rheumatic disease [14] .
Differentially expressed genes in B19-seropositive persons were identified using a microarray, with confirmation by realtime PCR at a second time point. This approach is, therefore, highly stringent and ensures that irreproducible although significant differences in gene expression at a single time point are not mistakenly interpreted as a real association that might reflect a biological effect. By use of this approach, 6 genes were identified as being significantly differentially expressed in the absence of detectable viral transcript. Although the fold difference values of these 6 genes between seropositive and seronegative groups, as detected by PCR, were smaller than what would normally be accepted as having likely biological significance, both groups consisted of healthy persons and so would not be expected to show major differences in gene regulation. These genes perform particular functions in the cytoskeleton, in integrin signaling (figure 3), in HLA class III, and in tumor suppression (table 4) .
Possible explanations that may account for such a finding include a prolonged immune response, supported by previous reports of prolonged viremia and cytokine disturbances after acute infection [2, 15] , and possible integration of viral genome, as has been shown to occur with adeno-associated viruses [16, 17] and with another autonomous parvovirus, minute virus of mice (MVM) [18] . This possibility is supported by a single study in which B19 DNA was found to be integrated into human DNA from PBMCs in healthy persons at low frequency [19] . B19 infection leads to a prolonged viremia during which the virus has access to hemopoietic stem cells. Infection of and integration into these cells represents a plausible event that could result in such long-term effects on human gene regulation. Long-term effects on hemopoietic stem cells have been documented during murine infection with the parvovirus MVMi [20] .
Both aspects of the present study highlight the importance of integrin signaling/cytoskeleton and negative regulation of cell growth/tumor suppression in B19 pathogenesis. These pathways have previously documented involvement in the pathogenesis of infection with either parvovirus B19 or 1 or more of the animal parvoviruses. Thus, b integrins have been shown to be a coreceptor for cell entry of B19 virus [21] . The actin cytoskeleton has been shown to be essential during the trafficking of canine parvovirus [22] and MVM [23] towards the nucleus. Increased production of the major histocompatibility complex class III G8 protein, encoded by the c6orf48 gene, is interesting in light of previously documented immunogenetic influences [4, 24] and the role of this protein as a tissue-protective factor produced in response to chronic inflammation, which has been shown to occur after acute B19 infection [2, 15] . Oncosuppression is a feature of infection with various parvoviruses and is a complex, in vivo phenomenon that may manifest in various ways [25] . Ras-related genes feature in both the SNP (FDFT1, RASGRP2, and CENTG2) and gene expression (RASSF5) parts of the present study. RASSF5 is a plasma membrane GTP-binding protein that modulates intracellular signal-transduction pathways, including the integrin signaling pathway ( figure 3 ). RASSF5 has a Ras-association domain and has been shown to induce cell polarization and to accumulate at immunologic synapses [26] . RASSF5 is a homolog of NORE1 in mice and is a tumor suppressor [27] and regulator of apoptosis [28] .
We are not aware of any other such studies of other virus infections. However, under the assumption that these findings represent a real biological phenomenon and given the restricted size of the B19 genome, it is possible that such phenomena may be observed with carriage of several other viruses that are known to persist after acute infection in the human host. If this is true, one could speculate that sequential persistent virus infections throughout life (for example, herpes viruses, parvovirus B19, adenovirus, and pox viruses), may result in cumulative and particular alterations in gene regulation, which could have an important bearing on immune responsiveness and development or prevention of chronic disease. In conclusion, the present study suggests important roles for both integrin signaling/cytoskeleton and negative regulation of cell growth in the pathogenesis of parvovirus B19 infection.
